title: [Primary angioplasty in acute coronary syndromes with ST-segment elevation: experience of three Alsacian centers].
abstract: The guidelines of the European Society of Cardiology, published in 2003, consider primary angioplasty as the preferred treatment strategy in acute coronary syndromes with ST-segment elevation, if the procedure can be performed within 90 min after first medical contact. We report the experience of three Alsacian centers running a common prospective registry with 2504 consecutive patients enroled between January 1999 and December 2004. The average age of the patients was 62 years with a proportion of 24% women. The time delay "pain to admission" was > or =3 hours in 55.9% of the cases. The treatment delay "door to catheterisation needle" was 59 min and the mean delay "door-to-reperfusion" was 79 min. The study population was representative of the real world including subsets of patients with a particulary high risk profile: age > or =70 years in 33%, a Killip grade > or =3 in 11.5%, rescucitated sudden death in 6.6% and cardiogenic shock in 10.9% of the patients respectively. The immediate procedural success rate (Timi 3 flow) in the treated coronary artery was 96.5%. The overall inhospital mortality-rate was 9.3%. The combinations of rescucitated sudden death--cardiogenic shock or age > or =75 years--cardiogenic shock were associated with a poor clinical outcome and mortality rates of 69% and 72.6% respectively, where as in the absence of abovementioned clinical high risk settings, the mortality rate was as low as 1.4%. The overall bleeding complication rate was 1.4%. The policy of systematic primary angioplasty in acute coronary syndromes with ST-Segment elevation appears to be coherent. The procedural complications and the in-hospital mortality rates were low, except in the presence of above mentioned clinical high risk settings.
authors.affiliation: Centre Hospitalier, Fédération de cardiologie, Haguenau.
authors.forename: M
authors.initials: M
authors.lastname: Hanssen
authors.forename: Y
authors.initials: Y
authors.lastname: Gottwalles
authors.forename: J P
authors.initials: JP
authors.lastname: Monassier
authors.forename: P
authors.initials: P
authors.lastname: Couppie
authors.forename: J
authors.initials: J
authors.lastname: Boulenc
authors.forename: L
authors.initials: L
authors.lastname: Jacquemin
authors.forename: F
authors.initials: F
authors.lastname: De Poli
authors.forename: L
authors.initials: L
authors.lastname: Levai
authors.forename: R
authors.initials: R
authors.lastname: El Belghiti
mesh_terms: D000293:Adolescent; D000328:Adult; D000367:Age Factors; D000368:Aged; D000369:Aged, 80 and over; D000789:Angina, Unstable / Q000401:mortality / Q000628:therapy*; D015906:Angioplasty, Balloon, Coronary; D016757:Death, Sudden, Cardiac; D004562:Electrocardiography; D005260:Female; D005602:France / Q000453:epidemiology; D017052:Hospital Mortality; D006801:Humans; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000401:mortality / Q000628:therapy*; D011446:Prospective Studies; D012042:Registries; D019233:Retreatment; D018570:Risk Assessment; D012770:Shock, Cardiogenic / Q000401:mortality; D013997:Time Factors